Overview A Study of NK012 in Patients With Relapsed Small Cell Lung Cancer Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary The purpose of this study is to determine whether NK012 is safe and effective in the treatment of relapsed small cell lung cancer. Phase: Phase 2 Details Lead Sponsor: Nippon Kayaku Co., Ltd.Nippon Kayaku Co.,Ltd.